An infant with HDFN can experience a number of symptoms, including lethargy, floppiness, excessive fatigue and irritability.

In early 2024, nipocalimab was granted Breakthrough Therapy designation by the US Food and Drug Administration (FDA) for the treatment of hemolytic disease of the fetus and newborn (HDFN) based on ...

FcRn protects IgG and albumin from catabolism, transports IgG across the placenta, and regulates IgG function. Blocking or augmenting FcRn can decrease autoimmune antibodies and enhance drug ...

A group of researchers shared their hospital protocol in managing women of childbearing age with Rhesus D (RhD) negativity ...

Targeting the neonatal Fc receptor (FcRn) has emerged as a promising therapeutic approach in reducing fetal morbidity and mortality in hemolytic disease of the fetus and newborn (HDFN), according to a ...

Hemolytic anemia occurs when red blood cells are destroyed faster than they can be replaced. The loss of red blood cells means that fewer are available to carry oxygen and nutrients to tissues or ...

is used for severe hemolytic disease of the newborn. Partial or dilutional exchange transfusion, done for polycythemia, consists of removing whole blood and replacing it milliliter for milliliter ...

Women who suffer from low iron levels in pregnancy are much more likely to have a baby with heart disease, experts have found in a “gamechanger” discovery. For the first time, researchers have ...

Yet this committee, which helped prevent newborn death and suffering from chronic disease, got terminated. Kennedy did tell reporters they expected to make errors: “We’re going to do 80% cuts ...

The prenatal DNA sequencing market is expected to grow from $2.5 billion in 2024 to $5.3 billion by 2029, driven by rising maternal age, increased birth rates, and advancements in non-invasive testing ...